Introduction
Brand name: Moxiact‑K
Manufacturer: Astemax Biotech Pvt. Ltd.
Product: Moxifloxacin + Ketorolac ophthalmic solution (eye drop)
Moxiact‑K is a sterile combination antibiotic‑and‑anti‑inflammatory eye drop containing moxifloxacin (a fourth‑generation fluoroquinolone) and ketorolac (a non‑steroidal anti‑inflammatory drug, NSAID), used for managing bacterial eye infections with associated pain, redness, and inflammation.
Typical composition (generic standard)
Moxifloxacin 0.5% (5 mg/mL)
Broad‑spectrum antibiotic effective against many Gram‑positive and Gram‑negative ocular pathogens; prevents and treats bacterial conjunctivitis, keratitis, and peri‑surgical infections.
Ketorolac 0.5% (5 mg/mL)
NSAID that inhibits prostaglandin synthesis, reducing pain, swelling, redness, and post‑operative ocular inflammation.
Key indications
Bacterial conjunctivitis and keratitis where infection control and symptom relief are both required.
Post‑operative use after cataract surgery, LASIK, or other ocular procedures to prevent infection and minimise inflammation, pain, and discomfort.
Situations with significant ocular surface irritation, pain, and redness due to acute bacterial infection, under specialist supervision.
Typical use and precautions
Common dosing: 1 drop in the affected eye(s) 3–4 times daily during the acute phase; frequency may be reduced during tapering as per ophthalmologist’s plan.
